Once damaged, it has limited ability to heal, leaving millions of people worldwide with permanent paralysis. However, a groundbreaking clinical trial in Japan has provided a glimmer of hope, showing ...

Researchers sought to determine whether using HRD sources for HSCT would be effective for pediatric patients with hematologic cancers compared with UCB sources.

It may be disturbing to characterize human bodies in such commodifying terms, but the unavoidable reality is that human ...